Givaudan SA (GVDBF)
| Market Cap | 37.17B -19.7% |
| Revenue (ttm) | 9.42B +0.8% |
| Net Income | 1.35B -1.7% |
| EPS | 145.61 -1.8% |
| Shares Out | n/a |
| PE Ratio | 27.52 |
| Forward PE | 25.81 |
| Dividend | 91.36 (2.28%) |
| Ex-Dividend Date | Mar 23, 2026 |
| Volume | 4 |
| Open | 4,000.00 |
| Previous Close | 3,938.50 |
| Day's Range | 4,000.00 - 4,000.00 |
| 52-Week Range | 3,220.99 - 5,065.37 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 23, 2026 |
About Givaudan
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, in... [Read more]
Financial Performance
In 2025, Givaudan's revenue was 7.47 billion, an increase of 0.81% compared to the previous year's 7.41 billion. Earnings were 1.07 billion, a decrease of -1.74%.
Financial numbers in CHF Financial StatementsNews
Givaudan price target raised to CHF 3,300 from CHF 3,100 at Barclays
Barclays analyst Alex Sloane raised the firm’s price target on Givaudan (GVDNY) to CHF 3,300 from CHF 3,100 and keeps an Equal Weight rating on the shares. The company’s second…
Givaudan price target raised to CHF 2,900 from CHF 2,875 at Morgan Stanley
Morgan Stanley analyst Lisa De Neve raised the firm’s price target on Givaudan (GVDNY) to CHF 2,900 from CHF 2,875 and keeps an Equal Weight rating on the shares. Published…
Swiss Market Ends Modestly Higher; Givaudan Soars On Rating Upgrade
(RTTNews) - The Switzerland market started off on a slightly weak note on Tuesday but swiftly moved into positive territory and then stayed firm throughout the session to close modestly up.
Givaudan upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte upgraded Givaudan (GVDNY) to Buy from Hold with a price target of CHF 3,300, up from CHF 3,000. The firm says the company is seeing…
Givaudan upgraded to Buy from Sell at Goldman Sachs
Goldman Sachs upgraded Givaudan (GVDNY) to Buy from Sell with a price target of CHF 3,500, up from CHF 2,900. The firm made seven rating changes in European chemicals, “positioning…
Givaudan downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 3,000, down from CHF 3,600. The firm cites the stock’s premium multiple for the downgrade.
PepsiCo, Givaudan, Smurfit Westrock and Statkraft sign renewable energy deal
PepsiCo (PEP), Givaudan (GVDNY), Smurfit WestRock (SW) and Statkraft have announced a 10-year Virtual Power Purchase Agreement, or VPPA, with an underlying wind asset in Spain which is undergoing repo...
Givaudan price target raised to CHF 2,920 from CHF 2,915 at Berenberg
Berenberg raised the firm’s price target on Givaudan (GVDNY) to CHF 2,920 from CHF 2,915 and keeps a Hold rating on the shares.
Givaudan upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Givaudan (GVDNY) to Overweight from Neutral with an unchanged price target of CHF 3,600. The firm believes the stock’s de-rating and the company’s sales growth “may have troughed.”…
Givaudan beats sales estimates as fragrance demand lifts shares
Swiss fragrance and flavour maker Givaudan reported stronger-than-expected first-quarter sales growth, supported by robust demand in its fragrance and consumer products segment. The company said its L...
Givaudan Earnings release: Q1 2026
Givaudan released its Q1 2026 earnings on April 14, 2026, summarizing the period's financial results.
Givaudan Slides: Investor presentation
Givaudan has posted slides in relation to its latest quarterly earnings report, which was published on April 9, 2026.
Givaudan downgraded to Hold from Buy at Berenberg
Berenberg downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 2,915, down from CHF 3,580. The firm is concerned the company’s organic sales growth could continue…
Givaudan downgraded to Equal Weight from Overweight at Barclays
Barclays downgraded Givaudan (GVDNY) to Equal Weight from Overweight with a price target of CHF 3,050, down from CHF 3,550. The firm says a “renewed spike” in costs from the…
Givaudan downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 3,000, down from CHF 3,750. The firm adjusted ratings in the European chemicals and ingredients…
Givaudan price target lowered to CHF 2,875 from CHF 3,000 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Givaudan (GVDNY) to CHF 2,875 from CHF 3,000 and keeps an Equal Weight rating on the shares.
Givaudan price target lowered to CHF 3,150 from CHF 3,350 at Citi
Citi analyst Ranulf Orr lowered the firm’s price target on Givaudan (GVDNY) to CHF 3,150 from CHF 3,350 and keeps a Neutral rating on the shares.
Exclusive: India probes fragrance giants Givaudan, Firmenich, IFF over deals not to poach workers
India's antitrust watchdog is investigating global fragrance makers Givaudan , Firmenich and International Flavors & Fragrances over accusations of striking anti-poaching deals that can harm workers, ...
Givaudan Slides: Investor presentation
Givaudan has posted slides in relation to its latest quarterly earnings report, which was published on March 2, 2026.
Givaudan downgraded to Sell from Buy at Goldman Sachs
Goldman Sachs analyst Georgina Fraser downgraded Givaudan (GVDNY) to Sell from Buy with a price target of CHF 2,900, down from CHF 4,100. The firm adjusted seven ratings in the…
Givaudan price target lowered to CHF 3,350 from CHF 3,500 at Citi
Citi analyst Ranulf Orr lowered the firm’s price target on Givaudan (GVDNY) to CHF 3,350 from CHF 3,500 and keeps a Neutral rating on the shares.
Givaudan price target lowered to CHF 3,000 from CHF 3,200 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Givaudan (GVDNY) to CHF 3,000 from CHF 3,200 and keeps an Equal Weight rating on the shares.
Givaudan price target lowered to CHF 3,600 from CHF 4,000 at JPMorgan
JPMorgan analyst Celine Pannuti lowered the firm’s price target on Givaudan (GVDNY) to CHF 3,600 from CHF 4,000 and keeps a Neutral rating on the shares.
Givaudan price target lowered to CHF 3,750 from CHF 3,900 at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte lowered the firm’s price target on Givaudan (GVDNY) to CHF 3,750 from CHF 3,900 and keeps a Buy rating on the shares. Published first on…
Givaudan Earnings Call Transcript: H2 2025
2025 saw robust sales and cash flow growth, with strong performance in Fragrance & Beauty and resilience in Taste & Wellbeing. High-growth markets and local clients drove results, while the outlook targets 4–6% sales growth and >12% free cash flow.